28DIGITAL Celebrates VoiceMed’s Third-Place Win at the 2025 EIT Innovation Awards

28DIGITAL is proud to announce that VoiceMed, a pioneering digital-wellbeing startup in our Equity Portfolio, has been awarded third prize in the EIT Innovation Team Award category at the 2025 EIT Awards, one of Europe’s most prestigious recognitions for breakthrough innovation.

Held in Budapest on Tuesday this week, this year’s ceremony brought together the EIT Awards, the EIT Jumpstarter Grand Finale, and the EIT Red Kalyna celebrations, forming a landmark gathering of Europe’s most promising innovators, entrepreneurs, and ecosystem builders.

Selected from hundreds of applicants across the continent, VoiceMed stood out for its groundbreaking work in AI-powered vocal biomarkers, a transformative field enabling health analysis through nothing more than a smartphone.

VoiceMed’s solution analyzes breath and voice to provide insights into cardiorespiratory fitness and lung function, empowering individuals to take early action on cardiovascular and respiratory risks—two leading global causes of mortality.

This win underscores the alignment between VoiceMed’s mission and 28DIGITAL’s vision of Tech. Talent. Trust., showcasing how responsible, human-centric digital innovation can meaningfully impact lives.

“Today’s winners demonstrate why Europe needs strong innovation ecosystems that connect education, research, and business,” said Antoaneta Angelova Krasteva, Director at the European Commission’s DG EAC. EIT Director Martin Kern added: “These innovators show how European talent can turn bold ideas into global impact.”

VoiceMed’s achievement places them among Europe’s leading deep tech innovators, recognized alongside projects such as Italy’s AI Automated Industrial Analytics (first place) and Estonia’s BRIGHT Project (second place) in the Innovation Team category.

Beyond the awards, the ceremony highlighted Europe’s expanding innovation network, with the EIT Community now spanning over 2,420 partners, supporting 9,900 ventures, and generating €9.5 billion in external investment.

At 28DIGITAL, we believe that vocal biomarkers represent a paradigm shift in preventive healthcare—one where sound becomes a gateway to early detection across cardiovascular, respiratory, mental-health, and neurodegenerative conditions. VoiceMed exemplifies how this technology can turn everyday devices into tools for healthier, more proactive living.

“This achievement confirms the enormous potential of VoiceMed’s technology and the strength of Europe’s innovation ecosystem,” said Federico Menna, CEO of 28DIGITAL. “We invest in founders who combine purpose with cutting-edge science, and VoiceMed is a perfect example of how AI can be applied responsibly to improve people’s lives. We are proud to support their journey as they push the boundaries of digital health.”

Sign up for updates

Receive the latest news and events updates by subscribing to our newsletter.

Sign up for our Newsletter

For media contacts

Are you a member of the media and would you like to contact us?
→ Get in touch with us here

Continue reading

Scroll up

Initiated by the EIT